ctDNA guiding adjuvant immunotherapy in urothelial carcinomaThomas Powles, Sanjeev Mariathasan, Nicole N. Davarpanah et al.|Nature|2021Cited by 603
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancerXueping Qu, Carlos Bais|Nature Communications|2025Cited by 16